ARE
Neutral signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. 3 purchase disclosures year to date, a thin reading
- Financial indicators Pulls against a bullish reading. Current ratio 0.43 · operating margin -40%
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Pulls against a bullish reading. Interesting trend — weekly bias down
ACHAT TOTAL: 10 000 titres (~479 800,00 $ US)
- Insiders
- MARCUS JOEL S
- Total bought
-
$479,800
Avg buy (VWAP, 90d window) $47.98 vs last close $49.93 (+4.1%)
- Total sold
-
—
Avg sell (VWAP, 90d window) $50.67 vs last close $49.93 (-1.5%)
- Last activity
- 2026-09-11
- Liquidity
- Liquid $90,715,615/day · 20d vol
- Last synced
-
2026-09-25 21:10:08
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-11 | Fukuzaki-Carlson Kristina | Sell | 16,810 | $50.51 | $849,073 | Form 4 |
| 2026-09-11 | MARCUS JOEL S | Buy | 5,000 | $49.68 | $248,400 | Form 4 |
| 2026-08-31 | Gavinet Andres | Sell | 10,000 | $50.93 | $509,300 | Form 4 |
| 2026-08-17 | MARCUS JOEL S | Buy | 5,000 | $46.28 | $231,400 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Neutral signalScored 2026-09-25
ARE presents a deeply concerning financial profile with critically low liquidity (current ratio 0.43), negative operating income, and unsustainable leverage, leaving virtually no margin of safety for investors.
The first sentence of the analysis written for ARE on 2026-09-25 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 68.9% | 70.2% | 69.8% | 69.6% | 70.4% | |
| Ebit Margin | -33.3% | 22.8% | 12.5% | 29.7% | 37.8% | |
| Ebitda Margin | 12.1% | 62.3% | 51.0% | 68.6% | 76.7% | |
| Operating Profit Margin | -40.5% | 25.2% | 24.3% | 23.8% | 24.3% | |
| Pretax Profit Margin | -41.0% | 16.7% | 9.9% | 26.0% | 31.0% | |
| Continuous Operations Profit Margin | -41.0% | 16.7% | 9.9% | 26.0% | 31.0% | |
| Net Profit Margin | -48.2% | 10.6% | 3.6% | 20.3% | 27.1% | |
| Bottom Line Profit Margin | -48.4% | 10.2% | 3.3% | 19.9% | 26.7% | |
| Current Ratio | 0.431 | 0.400 | 0.391 | 0.582 | 0.408 | |
| Quick Ratio | 0.431 | 0.400 | 0.391 | 0.582 | 0.408 | |
| Solvency Ratio | -0.005 | 0.101 | 0.085 | 0.119 | 0.124 | |
| Cash Ratio | 0.252 | 0.282 | 0.309 | 0.493 | 0.209 | |
| Price To Earnings Ratio | -5.799 | 54.194 | 234.759 | 45.808 | 58.214 | |
| Price To Earnings Growth Ratio | 0.010 | 0.232 | -2.828 | -2.699 | -3.175 | |
| Forward Price To Earnings Growth Ratio | 0.010 | 0.232 | -2.828 | -2.699 | -3.175 | |
| Price To Earnings Diluted Ratio | -5.799 | 54.194 | 234.759 | 45.808 | 58.366 | |
| Price To Earnings Diluted Growth Ratio | 0.010 | 0.232 | -2.828 | -2.734 | -3.207 | |
| Price To Book Ratio | 0.539 | 0.938 | 1.173 | 1.241 | 2.023 | |
| Price To Sales Ratio | 2.807 | 5.504 | 7.622 | 9.141 | 15.538 | |
| Price To Free Cash Flow Ratio | 5.897 | 11.157 | 13.288 | 18.194 | -5.180 | |
| Price To Operating Cash Flow Ratio | 5.897 | 11.157 | 13.288 | 18.194 | 32.427 | |
| Debt To Assets Ratio | 0.374 | 0.340 | 0.318 | 0.297 | 0.305 | |
| Debt To Equity Ratio | 0.825 | 0.713 | 0.633 | 0.557 | 0.570 | |
| Debt To Capital Ratio | 0.452 | 0.416 | 0.388 | 0.358 | 0.363 | |
| Long Term Debt To Capital Ratio | 0.438 | 0.406 | 0.378 | 0.349 | 0.345 | |
| Financial Leverage Ratio | 2.203 | 2.098 | 1.991 | 1.872 | 1.867 | |
| Working Capital Turnover Ratio | -2.458 | -2.548 | -2.963 | -2.987 | -2.920 | |
| Operating Cash Flow Ratio | 0.648 | 0.768 | 0.815 | 0.774 | 0.583 | |
| Operating Cash Flow Sales Ratio | 0.476 | 0.493 | 0.574 | 0.502 | 0.479 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.000 | 1.000 | 1.000 | 1.000 | -6.260 | |
| Debt Service Coverage Ratio | 0.622 | 10.218 | 8.318 | 18.758 | 3.925 | |
| Interest Coverage Ratio | -5.303 | 4.142 | 9.305 | 6.512 | 3.603 | |
| Short Term Operating Cash Flow Coverage Ratio | 4.004 | 0.000 | 16.313 | 0.000 | 3.742 | |
| Operating Cash Flow Coverage Ratio | 0.111 | 0.118 | 0.139 | 0.122 | 0.109 | |
| Capital Expenditure Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.138 | |
| Dividend Paid And Capex Coverage Ratio | 1.551 | 1.674 | 1.924 | 1.708 | 0.126 | |
| Dividend Payout Ratio | -0.637 | 2.782 | 8.177 | 1.453 | 1.148 | |
| Enterprise Value Multiple | 57.015 | 15.264 | 22.604 | 18.839 | 25.733 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 68.9% | ▼-1.2% | ▼-0.8% |
| Ebit Margin | -33.3% | ▼-56.2% | ▼-47.2% |
| Ebitda Margin | 12.1% | ▼-50.1% | ▼-42.0% |
| Operating Profit Margin | -40.5% | ▼-65.7% | ▼-51.9% |
| Pretax Profit Margin | -41.0% | ▼-57.7% | ▼-49.5% |
| Continuous Operations Profit Margin | -41.0% | ▼-57.7% | ▼-49.5% |
| Net Profit Margin | -48.1% | ▼-58.7% | ▼-50.8% |
| Bottom Line Profit Margin | -48.4% | ▼-58.6% | ▼-50.7% |
| Current Ratio | 0.431 | ▲0.030 | ▼-0.012 |
| Quick Ratio | 0.431 | ▲0.030 | ▼-0.012 |
| Solvency Ratio | -0.005 | ▼-0.106 | ▼-0.090 |
| Cash Ratio | 0.252 | ▼-0.030 | ▼-0.057 |
| Price To Earnings Ratio | -5.799 | ▼-59.993 | ▼-83.234 |
| Price To Earnings Growth Ratio | 0.010 | ▼-0.222 | ▲1.702 |
| Forward Price To Earnings Growth Ratio | 0.010 | ▼-0.222 | ▲1.702 |
| Price To Earnings Diluted Ratio | -5.799 | ▼-59.993 | ▼-83.264 |
| Price To Earnings Diluted Growth Ratio | 0.010 | ▼-0.222 | ▲1.715 |
| Price To Book Ratio | 0.539 | ▼-0.399 | ▼-0.644 |
| Price To Sales Ratio | 2.807 | ▼-2.697 | ▼-5.315 |
| Price To Free Cash Flow Ratio | 5.897 | ▼-5.259 | ▼-2.774 |
| Price To Operating Cash Flow Ratio | 5.897 | ▼-5.259 | ▼-10.295 |
| Debt To Assets Ratio | 0.374 | ▲0.035 | ▲0.047 |
| Debt To Equity Ratio | 0.825 | ▲0.112 | ▲0.165 |
| Debt To Capital Ratio | 0.452 | ▲0.036 | ▲0.057 |
| Long Term Debt To Capital Ratio | 0.438 | ▲0.032 | ▲0.055 |
| Financial Leverage Ratio | 2.203 | ▲0.105 | ▲0.197 |
| Working Capital Turnover Ratio | -2.458 | ▲0.090 | ▲0.317 |
| Operating Cash Flow Ratio | 0.648 | ▼-0.121 | ▼-0.070 |
| Operating Cash Flow Sales Ratio | 0.476 | ▼-0.017 | ▼-0.029 |
| Free Cash Flow Operating Cash Flow Ratio | 1.000 | 0.000 | ▲1.452 |
| Debt Service Coverage Ratio | 0.622 | ▼-9.597 | ▼-7.747 |
| Interest Coverage Ratio | -5.303 | ▼-9.445 | ▼-8.955 |
| Short Term Operating Cash Flow Coverage Ratio | 4.004 | ▲4.004 | ▼-0.808 |
| Operating Cash Flow Coverage Ratio | 0.111 | ▼-0.007 | ▼-0.009 |
| Capital Expenditure Coverage Ratio | 0.000 | 0.000 | ▼-0.028 |
| Dividend Paid And Capex Coverage Ratio | 1.551 | ▼-0.123 | ▲0.155 |
| Dividend Payout Ratio | -0.637 | ▼-3.420 | ▼-3.222 |
| Enterprise Value Multiple | 57.015 | ▲41.752 | ▲29.124 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $8.34B | $16.79B | $21.67B | $23.55B | $32.76B | |
| Enterprise value | $20.55B | $28.98B | $32.75B | $33.29B | $41.62B | |
| EV / Sales | 6.92x | 9.50x | 11.52x | 12.92x | 19.74x | |
| EV / Op. cash flow | 14.53x | 19.27x | 20.08x | 25.72x | 41.20x | |
| EV / Free cash flow | 14.53x | 19.27x | 20.08x | 25.72x | -6.58x | |
| EV / EBITDA | 57.02x | 15.26x | 22.60x | 18.84x | 25.73x | |
| Net debt / EBITDA | 33.88x | 6.42x | 7.65x | 5.51x | 5.48x | |
| Current ratio | 0.43x | 0.40x | 0.39x | 0.58x | 0.41x | |
| Income quality | -0.98x | 2.95x | 5.80x | 1.93x | 1.54x | |
| Graham number | — | $66 | $38 | $92 | $98 | |
| Graham net-net | -$83 | -$84 | -$79 | -$74 | -$73 | |
| Tax burden | 117.6% | 63.2% | 36.9% | 77.8% | 87.3% | |
| Interest burden | 122.9% | 73.3% | 79.1% | 87.7% | 82.2% | |
| Working capital | -$1.24B | -$1.17B | -$1.22B | -$699.0M | -$1.03B | |
| Invested capital | -$140.4M | $381.4M | $391.7M | $1.26B | $846.0M | |
| Return on assets | -4.2% | 0.9% | 0.3% | 1.5% | 1.9% | |
| Operating ROA | -3.4% | 2.1% | 1.9% | 1.9% | 1.9% | |
| Return on tangible assets | -4.2% | 0.9% | 0.3% | 1.5% | 1.9% | |
| Return on equity | -9.2% | 1.8% | 0.6% | 2.7% | 3.5% | |
| Return on invested capital | -3.7% | 2.2% | 2.0% | 1.8% | 1.8% | |
| Return on capital employed | -3.8% | 2.2% | 2.0% | 1.8% | 1.8% | |
| Earnings yield | -17.2% | 1.9% | 0.5% | 2.2% | 1.7% | |
| Free cash flow yield | 17.0% | 9.0% | 7.5% | 5.5% | -19.3% | |
| Capex / Op. cash flow | 0.0% | 0.0% | 0.0% | 0.0% | 726.0% | |
| Capex / Depreciation | 0.0% | 0.0% | 0.0% | 0.0% | 957.1% | |
| Capex / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 347.9% | |
| SG&A / Sales | 3.9% | 5.5% | 7.0% | 6.9% | 7.2% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.4% | 2.0% | 2.9% | 2.2% | 2.3% | |
| Intangibles / Total assets | 0.0% | 0.8% | 1.3% | 1.7% | 2.0% | |
| Days sales outstanding | 40d | 20d | 8d | 9d | 16d | |
| Days payables outstanding | 202d | 215d | 223d | 182d | 301d | |
| Operating cycle | 40d | 20d | 8d | 9d | 16d | |
| Cash conversion cycle | -162d | -195d | -215d | -172d | -285d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-50.3%EV / Sales ▼-27.2%EV / EBITDA ▲+273.5%EV / Op. cash flow ▼-4.732Earnings yield ▼-0.191
Profitability
Return on equity ▼-0.111Return on assets ▼-0.051Return on invested capital ▼-0.059Return on capital employed ▼-0.059Operating ROA ▼-0.054Income quality ▼-3.929Tax burden ▲+0.543
Efficiency
Days sales outstanding ▲+19.609Days payables outstanding ▼-12.687Operating cycle ▲+19.609Cash conversion cycle ▲+32.296Capex / Sales n/aR&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.030Net debt / EBITDA ▲+27.456Working capital ▼-68630000.000Invested capital ▼-521776000.000Intangibles / Total assets ▼-0.008
Change over 5 years
Valuation
Market cap ▼-74.5%EV / Sales ▼-65.0%EV / EBITDA ▲+121.6%EV / Op. cash flow ▼-26.669Earnings yield ▼-0.189
Profitability
Return on equity ▼-0.128Return on assets ▼-0.061Return on invested capital ▼-0.055Return on capital employed ▼-0.056Operating ROA ▼-0.053Income quality ▼-2.527Tax burden ▲+0.303
Efficiency
Days sales outstanding ▲+23.994Days payables outstanding ▼-98.535Operating cycle ▲+23.994Cash conversion cycle ▲+122.529Capex / Sales ▼-3.479R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.022Net debt / EBITDA ▲+28.399Working capital ▼-217009000.000Invested capital ▼-986409000.000Intangibles / Total assets ▼-0.020
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-04-14 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2026-03-23 | Michael T. McCaul | Purchase | $100,001 - $250,000 |
| 2026-01-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-01-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-12-19 | Gilbert Ray Cisneros | Sale (Full) | $1,001 - $15,000 |
| 2025-11-18 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2025-09-18 | Michael T. McCaul | Purchase | $50,001 - $100,000 |
| 2025-08-26 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-07-25 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-05-15 | Robert P. Bresnahan | Sale (Full) | $1,001 - $15,000 |
| 2025-02-25 | Robert P. Bresnahan | Purchase | $1,001 - $15,000 |
| 2024-11-15 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-09-26 | Ritchie Torres | Purchase | $1,001 - $15,000 |
| 2023-11-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-10-31 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-08 | Lois Frankel | Sale (Full) | $1,001 - $15,000 |
| 2023-09-06 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-08-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-08-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-07-12 | Daniel Goldman | Sale (Full) | $15,001 - $50,000 |
| 2023-06-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-06-28 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-06-26 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-05-30 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2023-05-19 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-16 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2023-04-20 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-04-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-03-24 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-03-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-03-06 | Daniel Goldman | Purchase | $50,001 - $100,000 |
| 2023-01-09 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-11-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-11-02 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-08-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-07-28 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2022-06-17 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-02-17 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-02-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-01-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2020-07-27 | Dwight Evans | Purchase | $1,001 - $15,000 |
| 2020-02-20 | Mikie Sherrill | Sale (Full) | $1,001 - $15,000 |
Recent news
- 2026-09-15 California State Teachers Retirement System Increases Stock Holdings in Alexandria Real Estate Equities, Inc. $ARE California State Teachers Retirement System raised its stake in shares of Alexandria Real Estate Equities, Inc. (NYSE: ARE) by 5,099.4% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,557,341 shares of the real estate investment trust''s stock
- 2026-09-14 2 REITs, $0 I''d Invest: Here''s My Case Against The Crowd Favorites Most equity REITs are uninvestable for high dividend-seeking investors. However, there are some gems to be found. Bargain-hunting high-quality names could be a reasonable approach.
- 2026-09-13 Alexandria Real Estate: Despite Headwinds, It Remains A Buy Alexandria Real Estate Equities (ARE) remains a Buy, supported by a compelling margin of safety despite headwinds. ARE faces persistent supply-demand imbalances in key life science markets, but recent improvements in venture funding and leasing trends offer cautious optimism. Alexandria is responding defensively — asset sales, a 45% dividend cut, lower G&A, and a pivot to JV capital — as credit downgrades reflect the same headwinds already priced in.
- 2026-09-13 Alexandria Real Estate: The Risk Was At $220, Not At $51 Alexandria Real Estate has declined 75% in five years due to oversupply, higher rates, and a biotech funding slowdown. Despite recent negative rental rate changes and falling occupancy, ARE''s best-in-class assets are positioned for a flight to quality as supply dries up. Life sciences market fundamentals are stabilizing, with construction pipelines shrinking and key markets showing early signs of recovery.
- 2026-09-13 Everyone Is Avoiding These REITs: That''s The Opportunity Some of the most hated REIT sectors may offer the biggest upside. European REITs trade at unusually steep NAV discounts. Life science and tower REITs could recover as sentiment turns.
- 2026-09-09 Alexandria Real Estate Chief Accounting Officer Sells 10,000 Shares The Aug. 31 transaction was valued at $509,300. The sale involved shares equal to 9% of the stake held directly by the insider prior to the transaction.
- 2026-09-08 Alexandria Real Estate Equities, Inc. $ARE Shares Bought by Hsbc Holdings PLC Hsbc Holdings PLC grew its position in Alexandria Real Estate Equities, Inc. (NYSE: ARE) by 15.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,208,572 shares of the real estate investment trust''s stock after buying an additional
- 2026-09-04 Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments PASADENA, Calif., Sept. 4, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science and advanced technology innovation clusters, today recognizes Blood Cancer Awareness Month by highlighting its strategic investments and tenants developing life-saving therapies in hematology and oncology, as well as the company''s longstanding mission-critical engagement with the nation''s leading nonprofits focused on blood cancers.
- 2026-09-04 Alexandria Real Estate: We''ve Already Seen The Bottom, Next Is The Retest Alexandria Real Estate Equities, Inc. (ARE) is deeply undervalued, but technical entry timing is critical for optimal returns. ARE''s FFO faces near-term headwinds from major lease expirations in 2027, with recovery expected as new leases and projects ramp up. I target a $45 average entry, buying in tranches on further weakness or a breakout above $55, to balance value and momentum.
- 2026-09-02 Alexandria Real Estate Equities (ARE) Up 5.7% Since Last Earnings Report: Can It Continue? Alexandria Real Estate Equities (ARE) reported earnings 30 days ago. What''s next for the stock?